SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg1/24/2006 7:25:08 AM
   of 1826
 
Board of Directors Compensation Schedule.

On January 17, 2006, the Board of Directors of MGI PHARMA, INC. (the "Company") met and ratified the Compensation Committee's approval of the following compensation schedule for the non-employee members of the Board of Directors:

Board of Directors Annual Retainer: $25,000, payable quarterly, and 15,000 shares of common stock of the Company

Chairman of the Board of Directors Annual Retainer: $25,000, payable quarterly, and 15,000 shares of common stock of the Company

Board of Directors Meeting Fee in Person: $3,000

Board of Directors Meeting Fee by Phone: $1,000

Chairman of the Board of Directors Meeting Fee: an additional $1,000

Committee Meeting Fee for Committee Meeting Attendance: $1,000

Committee Meeting Fee Attendance for Chairman of the Audit Committee: an additional $1,000

The non-employee members are also able to elect prior to July 1 of each year to receive shares of Common Stock in lieu of their annual retainer. If a director makes this election, shares would be issued on the last business day of each quarter pursuant to awards under the Company's 1997 Stock Incentive Plan and would be valued as of the close of business on the date of issuance.

2005 Bonus Payments for Named Executive Officers

On January 17, 2006, the Board of Directors of the Company met and ratified the Compensation Committee's approval of the 2005 bonus payments for the Company's named executive officers (as defined in Item 402(a)(3) of Regulation S-K and as set forth below) in the amounts indicated:

Leon O. Moulder, Jr. $ 168,000
Martin J. Duvall $ 78,466
James C. Hawley $ 69,468
Mary Lynne Hedley $ 97,650
Eric P. Loukas $ 84,263

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext